SEP 11, 2026 · PHASE 1 TRIAL
A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity
ClinicalTrials.gov
Phase 1 registry record with no results posted; describes a planned bioavailability study designed to measure food and water effects on zenagamtide absorption in an estimated 320 participants with overweight or obesity.
Reported
Planned enrollment320
Primary outcome measureAUC, zenagamtide, steady state (ss): area u…
Study phasePhase 1